Sponsoring Agency HHS
    POP 3/30/17 - 3/31/22 (5 years)


The Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) conducts translational research in the area of human therapeutics development and aims to move small molecule and biologic drug candidates forward in the drug development pipeline, at which point, DPI will hand off the drug candidate to external partner(s) to bring the novel therapy to patients. The overall goal of this proposed project is to support the DPI drug development program by contracting for Chemistry, Manufacturing, and Control services. Specifically, this proposed project is designed to ensure DPI receives Active Pharmaceutical Ingredients and formulated Drug Product of sufficient quality and quantity to support IND-enabling, pre-clinical, and clinical studies. To accomplish this goal, the Government plans to solicit proposals from offerors having in-house capability in one or more of the following technical areas: (1) Manufacture and Analysis of Small Molecules; (2) Manufacture and Analysis of Synthetic Peptides, Oligonucleotides, and Related Substances; and (3) Manufacture and Analysis of Biopharmaceuticals.

  • $0 Aggregate Dollars Obligated
  • $0 Aggregate Base & Exercised Options
  • $0 Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts